Does the Senate vote on stem-cell research matter?
By Richard Hayes,
San Francisco Chronicle
| 07. 19. 2006
YES: It's a step toward needed oversight and regulation
After years of rancorous debate, Tuesday's vote by the U.S. Senate on a package of stem-cell research bills suggests that responsible bipartisan action actually may be possible.
Nineteen Republican senators broke with the anti-abortion base of their party and with President Bush, by voting to lift the restrictions imposed five years ago by the president on federal funding for stem-cell research.
On the other side of the aisle, pro-choice Democrats voted to support a companion bill banning the intentional creation and abortion of fetuses in order to use their tissues for experimental purposes. Although no one, as far as anyone knows, has proposed doing this at this time, the vote affirms that liberals and conservatives can agree that some forms of biomedical research are ethically unacceptable and should be prohibited.
Also encouraging was what was left out of the package, notably, any move to authorize federal funding for research cloning, a procedure fraught with risks. At one time, cloning was thought to be necessary for stem-cell therapy to work, but many scientists increasingly believe that this is not the case...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...